All Stories

  1. Family quality‐of‐life burden in chronic spontaneous urticaria: A multicentre study
  2. The OX40-OX40L Co-stimulatory pathway in dermatology: emerging frontiers for therapeutic approaches
  3. Chronic spontaneous urticaria: update on pathogenesis and therapeutic implications
  4. Urticária crônica espontânea: atualização na patogênese e implicações terapêuticas
  5. Dermatose terra firma‐forme exuberante em paciente idoso
  6. Exuberant terra firma-forme dermatosis in an elderly patient⋆
  7. Chronic pruritus: a narrative review
  8. Prurido crônico: revisão narrativa
  9. IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
  10. DRESS syndrome: an interaction between drugs, latent viruses, and the immune system
  11. Update on the pathogenesis of atopic dermatitis
  12. Treatment with risankizumab for nivolumab‐induced psoriasis in a patient with metastatic clear cell renal carcinoma
  13. Prurigo: review of its pathogenesis, diagnosis, and treatment
  14. Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
  15. Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study
  16. Association of non-fatal symmetrical peripheral gangrene and COVID-19
  17. Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses
  18. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
  19. New small molecules in dermatology: for the autoimmunity, inflammation and beyond
  20. JAK-STAT pathway inhibitors in dermatology
  21. Prevalence of filaggrin gene polymorphisms (exon-3) in patients with atopic dermatitis in a multiracial Brazilian population
  22. Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy
  23. Livedoid Vasculopathy: Clinical, Histopathological, and Therapy Evaluation
  24. Primary Cutaneous Cryptococcosis Caused by Cryptococcus gatti in an Elderly Patient
  25. Pityriasis rubra pilaris (type I) following ChAdOx1 COVID‐19 vaccine: A report of two cases with successful treatment with oral isotretinoin
  26. Vasculitis in the setting of COVID ‐19: from the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization
  27. Post‐COVID‐19 hair loss: prevalence and associated factors among 5,891 patients
  28. Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
  29. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
  30. M2 macrophage polarization in chronic spontaneous urticaria refractory to antihistamine treatment
  31. Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology department
  32. COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
  33. Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report
  34. Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals
  35. What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center
  36. Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS‐CoV‐2 in two Brazilian asymptomatic patients: the tip of the COVID‐19 hidden iceberg?
  37. International registry of dermatological manifestations secondary to COVID‐19 infection in 347 Hispanic patients from 25 countries
  38. A case of tuberculosis verrucosa cutis in Brazil undiagnosed for 15 years
  39. First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries
  40. A late diagnosis of hyperhomocysteinemia with probable evolution to verrucous elephantiasis nostra and leg ulcers
  41. Axillary papules: an uncommon location of lichen nitidus
  42. Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study
  43. Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice
  44. Livedoid vasculopathy in 75 Brazilian patients in a single‐center institution: Clinical, histopathological and therapy evaluation
  45. The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
  46. Sarcoidosis with necrobiosis‐lipoidica–like skin lesions: A challenge for the dermatologist
  47. Granuloma Annulare: a Review of the Literature
  48. From dermatological conditions to COVID ‐19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy
  49. Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data
  50. Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases
  51. Potential interactions of SARS‐CoV‐2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues
  52. Less is more: study on the different ways of closing surgical wounds after Mohs micrographic surgery
  53. Termo de consentimento informado: impacto na decisão judicial
  54. Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab
  55. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID ‐19 or asymptomatic infections due to SARS‐CoV ‐2?
  56. Lessons from dermatology about inflammatory responses in Covid‐19
  57. Unilateral verrucous plaque in a 14‐year‐old child
  58. Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis
  59. Grammatically uniform population initialization for grammar-guided genetic programming
  60. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
  61. Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
  62. Panniculitis as main clinical manifestation of alpha‐1 antitrypsin deficiency revealing a SerpinA1 gene mutation
  63. Botryomycosis in Patient With Pituitary Microadenome: A Case Report
  64. Multinucleate cell angiohistiocytoma: an uncommon cutaneous tumor in private practice
  65. Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis – Part II
  66. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  67. Clinical variability of the GJB4: c.35G > A gene variant : a study of a large Brazilian erythrokeratodermia pedigree
  68. Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis – part I
  69. A Rare Case of Multiple Variants of Porokeratosis in the Same Patient: The Clue of Dermoscopy for Diagnosis and Therapeutical Update
  70. Livedo Racemosa: Clinical, Laboratory, and Histopathological Findings in 33 Patients
  71. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod
  72. Diagnóstico e terapêutica precoce de vasculite leucocitoclástica: relato de caso
  73. Atypical clinical presentation of an Arthroderma gypseum infection in a renal transplant recipient
  74. Correlation Between Demographic and Tumor Characteristics in Non-melanoma Skin Cancers Submitted to Mohs Micrographic Surgery
  75. Trichophyton rubrum Elicits Phagocytic and Pro-inflammatory Responses in Human Monocytes Through Toll-Like Receptor 2
  76. Is macular lymphocytic arteritis limited to the skin? Long-term follow-up of seven patients
  77. Characterization of subtypes of Blastocystis sp. isolated from patients with urticaria, São Paulo, Brazil
  78. Ungual warts: comparison of treatment with intralesional bleomycin and electroporation in terms of efficacy and safety
  79. Panniculitides of particular interest to the rheumatologist
  80. Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology
  81. Association between frontal fibrosing alopecia and linear scleroderma “coup de sabre”
  82. What lessons can we learn from an apparent decrease in the use of topical drugs for psoriasis?
  83. In situ immune response in human dermatophytosis: possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection
  84. Radiotherapy-induced Pemphigus Foliaceous: a rare adverse effect of breast cancer therapy
  85. The train tracks sign is a valuable skin marker of envenomations caused by caterpillars
  86. Immunological Pathways in Hidradenitis Suppurativa: Current Concepts and Innovative Therapies
  87. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban
  88. Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients
  89. Histopathological and clinical evaluation of chronic spontaneous urticaria patients with neutrophilic and non-neutrophilic cutaneous infiltrate
  90. Livedoid vasculopathy: a compelling diagnosis
  91. Skin cancer prevention campaign in childhood: survey based on 3676 children in Brazil
  92. Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia -host interaction?
  93. Analysis of serum levels and cutaneous expression of Lipoprotein (a) in 38 patients with livedoid vasculopathy
  94. Longitudinal melanonychia due to voriconazole therapy during treatment of chromoblastomycosis
  95. Investigation of superficial mycosis in cutaneous allergy patients using topical or systemic corticosteroids
  96. Urticaria multiforme: Two cases with histopathological findings
  97. Hemodialysis and Kidney Transplantation as Predisposing Conditions to Onychomycosis
  98. Polymorphisms on IFNG , IL12B and IL12RB1 genes and paracoccidioidomycosis in the Brazilian population
  99. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall
  100. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: Report of 22 cases and literature review
  101. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital
  102. Use of Smartphones in Telemedicine: Comparative Study Between Standard and Teledermatological Evaluation of High-Complex Care Hospital Inpatients
  103. Thrombophilia: the dermatological clinical spectrum
  104. Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?
  105. Amantadine-Induced Livedo Racemosa
  106. Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?
  107. Chronic widespread dermatophytosis due to Trichophyton rubrum: a syndrome associated with a Trichophyton-specific functional defect of phagocytes
  108. Nail Sarcoidosis with and without Systemic Involvement: Report of Two Cases
  109. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol
  110. Chronic urticaria in adults: state-of-the-art in the new millennium
  111. TOLL-LIKE RECEPTORS (TLR) 2 AND 4 EXPRESSION OF KERATINOCYTES FROM PATIENTS WITH LOCALIZED AND DISSEMINATED DERMATOPHYTOSIS
  112. Monocyte-Derived Dendritic Cells from Patients with Dermatophytosis Restrict the Growth of Trichophyton rubrum and Induce CD4-T Cell Activation
  113. Atrophie Blanche
  114. Quality-of-life impairment in patients with livedoid vasculopathy
  115. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody
  116. In Situ Immune Response in Human Chromoblastomycosis – A Possible Role for Regulatory and Th17 T Cells
  117. Cutaneous New World Leishmaniasis on a Port-wine stain birthmark
  118. Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers
  119. Plasmacytoid dendritic cells in cutaneous lesions of patients with chromoblastomycosis, lacaziosis, and paracoccidioidomycosis: a comparative analysis
  120. Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
  121. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  122. Dermoscopy examination of petechial lesions in a patient with Dermatitis Herpetiformis
  123. Unilateral Livedoid Vasculopathy Associated With Involutional Phase of Cutaneous Infantile Hemangioma
  124. Tungiasis under dermoscopy: in vivo and ex vivo examination of the cutaneous infestation due to Tunga penetrans
  125. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis
  126. Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis
  127. Direct immunofluorescence findings and thrombophilic factors in livedoid vasculopathy: how do they correlate?
  128. Cutaneous Manifestations and Comorbidities in 60 Cases of Takayasu Arteritis
  129. Dermoscopy revealing a case of Tinea Nigra*
  130. The use of nested Polymerase Chain Reaction (nested PCR) for the early diagnosis of Histoplasma capsulatum infection in serum and whole blood of HIV-positive patients*
  131. Autoimmunity Diseases of the Skin
  132. Topical photoprotection in childhood and adolescence
  133. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts
  134. Immunoelectron microscopy study of superficial skin nerves in drug-induced acute urticaria
  135. Dermal dendrocytes FXIIIA+ phagocytizing extruded mast cell granules in drug-induced acute urticaria
  136. Back to our past...
  137. Association between multiple skin tags and insulin resistance
  138. Association of acanthosis nigricans and skin tags with insulin resistance
  139. Analysis of the Expression of Toll-like Receptors 2 and 4 in Keratinocytes of Patients with Extensive Dermatophytosis due Trichophyton rubrum
  140. Candida parapsilosiscandidaemia in a neonatal unit over 7 years: a case series study
  141. Vasculopatia livedoide: uma doença cutânea intrigante
  142. Micoses superficiais e os elementos da resposta imune
  143. Balanite plasmocitária de Zoon: relato de dois casos tratados com pimecrolimo
  144. Urticaria and dermographism in patients with adult-onset Still’s disease
  145. Aos Editores dos Anais Brasileiros de Dermatologia (Brazilian Annals of Dermatology)
  146. Livedoid vasculopathy secondary to high levels of lipoprotein(a)
  147. Entodermoscopia: dermatoscopia de epiluminescência para diagnose da pediculose
  148. Livedoid vasculopathy as a coagulation disorder
  149. Cimidíase (dermatose por percevejo): uma causa de prurigo a ser lembrada
  150. Bedbugs (Cimicidae infestation): the worldwide renaissance of an old partner of human kind
  151. E-learning program for medical students in dermatology
  152. Blefarite e tricomegalia induzidas pelo cetuximabe
  153. Avaliação clínica, dermatoscópica e histopatológica do nevo de Meyerson: relato de caso
  154. Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte II
  155. Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte I
  156. Cromoblastomicose: relato de 27 casos e revisão da literatura
  157. Tratamento do papiloma vírus humano na infância com creme de imiquimode a 5%
  158. Extensive long-standing chromomycosis due toFonsecaea pedrosoi: Three cases with relevant improvement under voriconazole therapy
  159. Ixodíase revelada pela microscopia de epiluminescência sem contato com a pele
  160. Histamina, receptores de histamina e anti-histamínicos: novos conceitos
  161. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study
  162. Dermatite verrucosa de Pedroso e Gomes (Cromomicose): 90 anos depois, ainda entre nós
  163. Teledermatologia: correlação diagnóstica em serviço primário de saúde
  164. Multiple pustules on trunk, face, oral mucosa, genital area, palms and soles, arthalgia and anterior chest wall osteitis
  165. A comparative study of single-dose treatment of chancroid using thiamphenicol versus Azithromycin
  166. Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+T cell activationin vitro
  167. Doações
  168. Vasculites dos médios e grandes vasos
  169. Prevalence of thrombophilia associated with leg ulcers
  170. S.138. Waldenstrom Hyperglobulinemic Purpura in a Patient with Chronic Mucocutaneous Candidiasis
  171. Manifestações cutâneas das trombofilias
  172. Fusariose em paciente imunocomprometido: sucesso terapêutico com voriconazol
  173. Influence of the human activity in the Atlantic Forest and in the prevalence of etiological agents of dermatophytosis in a coastal city of Southern Brazil Ubatuba (So Paulo)
  174. Urticaria unresponsive to antihistaminic treatment: An open study of therapeutic options based on histopathologic features
  175. Blisters on the legs
  176. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin
  177. Thalidomide inhibits human ultraviolet-B-induced skin inflammation?
  178. An unusual association between scalp psoriasis and ophiasic alopecia areata: the Renbök phenomenon
  179. Childhood-onset skin necrosis resulting from protein C deficiency
  180. The inflammatory response in drug-induced acute urticaria: ultrastructural study of the dermal microvascular unit
  181. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy
  182. Urticaria as a Cutaneous Sign of Adult-Onset Still's Disease
  183. Atrophia maculosa varioliformis cutis: a case with extrafacial involvement and familial facial lesions
  184. Tinea Faciei in an Infant Caused by Microsporum gypseum Simulating a Dry Impetigo
  185. Extensive nodular cutaneous amyloidosis: an unusual presentation
  186. Drug-Induced Hypersensitivity Syndrome Due to Anticonvulsants in a Two-Year-Old Boy
  187. Reações cutâneas graves adversas a drogas: aspectos relevantes ao diagnóstico e ao tratamento - Parte II
  188. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare
  189. Tinea Nigra: Report of Two Cases in Infants
  190. Acute generalized exanthematous pustulosis induced by ingestion of bamifylline
  191. Lichen sclerosus - a keratotic variant
  192. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone
  193. Keratosis lichenoides chronica: Report of a case developing after erythroderma
  194. Invasive hyalohyphomycosis due to Fusarium solani in a patient with acute lymphocytic leukemia
  195. 10.1016/j.abdp.2024.10.017
  196. 10.1016/j.abdp.2024.08.001
  197. 10.1016/j.abdp.2024.03.001
  198. 10.1016/j.abdp.2023.10.001
  199. 10.1016/j.abdp.2023.05.018
  200. 10.1016/j.abdp.2020.09.027
  201. 10.1016/j.abdp.2020.12.003
  202. 10.1016/j.abdp.2020.04.012
  203. 10.1016/j.abdp.2020.07.014
  204. 10.1016/j.abdp.2020.04.011
  205. 10.1016/j.abdp.2020.08.009
  206. 10.1016/j.abdp.2020.05.019
  207. 10.1016/j.abdp.2020.05.005
  208. 10.1016/j.abdp.2020.04.003
  209. 10.1016/j.abdp.2020.01.004
  210. 10.1016/j.abdp.2019.05.001
  211. Urticária e doenças sistêmicas
  212. Melanoma maligno cutâneo primário: estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo
  213. DEEP FUNGAL INFECTIONS